About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 35 record(s)
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Req # A-2022-00018
Request to provide the number of complaints received from 1990 to present against Air Canada (and its subsidiaries) and against WestJet regarding the requirement to pay for additional seating on a flight (domestic or international) to accommodate a disability.Organization: Canadian Human Rights Commission
February 2023
Req # A-2023-00024
Records pertaining to the complaint filed by the Quebec Association of First Nation and Inuit Police Directors (Association des directeurs de police des Premières Nations et Inuits du Québec) from January 2023 to January 2024.Organization: Canadian Human Rights Commission
February 2023
Req # A-2023-00026
Records detailing the annual expenses on consultants, their names, and the number of contracts for each year from 2015 to 2023.Organization: Canadian Human Rights Commission
February 2023
Req # A-2023-00030
All instructions, procedures, guidelines, or memoranda of best practices concerning the processing and/or assessment of mask-related complaints either issued to or within the CHRC during the years 2020, 2021, and 2022.Organization: Canadian Human Rights Commission
February 2023
Req # A-2023-00031
Statistical data pertaining to the complaints filed against Canada Revenue Agency, Canadian Border Services Agencies, Health Canada, Canadian Human Rights Commission, Canadian Transportation Agency, and Royal Canadian Mounted Police from 2017 to 2023.Organization: Canadian Human Rights Commission
February 2023
Req # A-2023-00032
Statistical data pertaining to the complaints filed against Royal Bank of Canada, Toronto Dominion, Scotia Bank, Canadian Imperial Bank of Commerce, and Bank of Montreal for each year, from 2010 to 2023.Organization: Canadian Human Rights Commission
February 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09228
All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023